Modeling in biopharmaceutics, pharmacokinetics and pharmacodynamics. Homogeneous and heterogeneous approaches

DOI10.1007/978-3-319-27598-7MaRDI QIDQ896049zbMATH OpenOpenAlexFDO

Authors Panos Macheras, Athanassios Iliadis

Publication date 11 December 2015

Published in Interdisciplinary Applied Mathematics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1007/978-3-319-27598-7

zbMATH Keywords

inverse problemsfractalsdiffusionsMichaelis-Menten type kinetics

Mathematics Subject Classification ID

Dynamical systems in biology (37N25) Research exposition (monographs, survey articles) pertaining to biology (92-02) Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45)

Recommendations

• Modeling in biopharmaceutics, pharmacokinetics, and pharmacodynamics. Homogeneous and heterogeneous approaches.
• Splines and compartment models. An introduction
• Fractal pharmacokinetics
• Mathematical concepts in pharmacokinetics and pharmacodynamics with application to tumor growth
• scientific article; zbMATH DE number 1462112

Cited in

(20)

• Computational Pharmacokinetics
• Assessing Bioavailablility of Drug Delivery Systems
• A fractional-order tumor growth inhibition model in PKPD
• Qualitative analysis of two systems of nonlinear first‐order ordinary differential equations for biological systems
• Phase-specific cancer-immune model considering acquired resistance to therapeutic agents
• Modeling in biopharmaceutics, pharmacokinetics, and pharmacodynamics. Homogeneous and heterogeneous approaches.
• Compartment Models with Memory
• Optimal control applied to a generalized Michaelis-Menten model of CML therapy
• Fractal pharmacokinetics
• High-throughput screening: establishing mathematical and physical models for bio-target im\-mo\-bilization
• Stochastic target-mediated drug disposition model based on birth-death process and its parameter inference using approximate Bayesian computation-MCMC
• Framework for solving dynamics of Ca²⁺ ion concentrations in liver cells numerically: Analysis of a non‐negativity‐preserving non‐standard finite‐difference method
• On the role of pharmacometrics in mathematical models for cancer treatments
• On the role of pharmacometrics and the objective in optimizing cancer therapies
• On the contribution of qualitative analysis in mathematical modeling of plasmid-mediated ceftiofur resistance
• A generalized kinetic model of fractional order transport dynamics with transit time heterogeneity in microvascular space
• Optimal control for a mathematical model for chemotherapy with pharmacometrics
• Saturable fractal pharmacokinetics and its applications
• Optimizing antimicrobial treatment schedules: some fundamental analytical results
• Biomedical engineering approach of pharmacokinetic problems: computer-aided design in pharmacokinetics and bioprocessing

This page was built for publication: Modeling in biopharmaceutics, pharmacokinetics and pharmacodynamics. Homogeneous and heterogeneous approaches

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q896049)